Today: September 4, 2015, 8:53 pm

Iran pharmaceuticals market estimated to be valued at US$4.2Bn in 2012
Iran Pharmaceuticals and Healthcare Report Q1 2014 - a new market research report on 2014-03-17 05:52:01
Iran´s pharmaceutical market is developing. Access to basic healthcare is widespread, reaching about 90% of the rural population and almost the entire urban population. The use of locally produced generic drugs is widespread, especially in the government healthcare sector. Furthermore, self-medication is common among the population, creating a strong (if not always legitimate) over-the-counter (OTC) drug market. Analysts estimate that the total market was worth IRR51.8bn (US$4.2bn) in 2012, with OTC medicines accounting for around 10-15% of the market by value.

Pharmaceuticals: IRR51,766bn (US$4.24bn) in 2012 to IRR69,973bn (US$2.12mn) in 2013; +35.2% in local currency terms and -50.0% in US dollar terms.

Healthcare: IRR363,006bn (US$29.76bn) in 2012 to IRR475,447bn (US$23.19bn) in 2013; +31.0% in local currency terms and -22.1% in US dollar terms.

Click for report details: ..

Browse all Healthcare and Medical Market Research Reports ..

Browse all Healthcare and Medical Company Profile Reports ..

Browse all Latest Market Research Reports ..

About Us is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles,’s online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.

Press Information

Published by
Mike King
London: +44 (0) 203 086 8600
Related Articles

Disclaimer: If you have any questions regarding information in this press release please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims the content included in this release.